Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tiziana Zanin"'
Autor:
Federica Ferrarini, Elisabetta Zulato, Massimo Moro, Paola Del Bianco, Cristina Borzi, Giovanni Esposito, Tiziana Zanin, Gabriella Sozzi, Stefano Indraccolo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionGenetically characterized patient-derived tumor xenografts (PDX) are a valuable resource to understand the biological complexity of cancer and to investigate new therapeutic approaches. Previous studies, however, lack information about me
Externí odkaz:
https://doaj.org/article/dcca2b4f92c84f669ae1e5232bb5ec17
Autor:
Ilaria Piga, Martina Verza, Francesca Montenegro, Giorgia Nardo, Elisabetta Zulato, Tiziana Zanin, Paola Del Bianco, Giovanni Esposito, Stefano Indraccolo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Metabolic profiling of cancer is a rising interest in the field of biomarker development. One bottleneck of its clinical exploitation, however, is the lack of simple and quantitative techniques that enable to capture the key metabolic traits of tumor
Externí odkaz:
https://doaj.org/article/ab3953097d8b4812b78e1c5823dacdb4
Autor:
Chiara Menin, Arcangela De Nicolo, Vanna Chiarion-Sileni, Maria Cristina Montesco, Simone Mocellin, Jacopo Pigozzo, Alessio Fabozzi, Antonio Sommariva, Paola Del Bianco, Tiziana Zanin, Lisa Elefanti, Carolina Zamuner, Camilla Stagni
Metastatic melanoma is characterized by complex genomic alterations, including a high rate of mutations in driver genes and widespread deletions and amplifications encompassing various chromosome regions. Among them, chromosome 7 is frequently gained
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c10bbe711c47f45d010194b118f49d11
https://doi.org/10.1158/1535-7163.c.6537814.v1
https://doi.org/10.1158/1535-7163.c.6537814.v1
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2572
Digital pathology has the potential to quantify tumor markers accurately and reproducibly with various cellular and subcellular localizations in tissues, thus filling a need in cancer research. As a case study, we quantified the percentage of necrosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b6eb3794e335e2e3b8c2fb050ec34e34
https://pubmed.ncbi.nlm.nih.gov/36161409
https://pubmed.ncbi.nlm.nih.gov/36161409
Autor:
Carolina Zamuner, Simone Mocellin, Chiara Menin, Arcangela De Nicolo, Lisa Elefanti, Maria Cristina Montesco, Alessio Fabozzi, Antonio Sommariva, Tiziana Zanin, Paola Del Bianco, Camilla Stagni, Vanna Chiarion-Sileni, Jacopo Pigozzo
Publikováno v:
Molecular Cancer Therapeutics. 17:1332-1340
Metastatic melanoma is characterized by complex genomic alterations, including a high rate of mutations in driver genes and widespread deletions and amplifications encompassing various chromosome regions. Among them, chromosome 7 is frequently gained
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dbc138199b6036c666a97f645d95af1
https://doi.org/10.1158/1535-7163.mct-17-1124
https://doi.org/10.1158/1535-7163.mct-17-1124